INCY vs NWSA · P/E 14, rev $5.14B vs rev $9.03B
Incyte Corporation (INCY) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
NWSA (NWSA) common stock.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. NWSA currently screens at market cap $0.
Not investment advice. Open the INCY and NWSA stock pages for the full models.
Not investment advice.